PRO-DEX, INC. Land
PRO-DEX, INC. (PDEX) had Land of $3.68 million as of 2023-03-31, per its 10-Q filed 2023-05-04.
Discontinued › Balance Sheet › Assets › Assets, Noncurrent › Property, Plant, and Equipment, before Accumulated Depreciation, Depletion, and Amortization › Land and Land Improvements
us-gaap:Land · last filed 2023-05-04
- 2023-03-31: Land $3.68M.
- 2022-12-31: Land $3.68M.
- 2022-06-30: Land $3.68M.
- 2022-03-31: Land $3.68M.
| Period end | Land |
|---|---|
| 2023-03-31 | $3.68M 10-Q · filed 2023-05-04 |
| 2022-12-31 | $3.68M 10-Q · filed 2023-02-02 |
| 2022-06-30 | $3.68M 10-Q · filed 2023-05-04 |
| 2022-03-31 | $3.68M 10-Q · filed 2022-05-05 |
| 2021-12-31 | $3.68M 10-Q · filed 2022-02-03 |
| 2021-06-30 | $3.68M 10-Q · filed 2022-05-05 |
| 2011-06-30 | $278.00K 10-K · filed 2012-09-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| Profound Medical Corp. (PROF) | $0.206B | -7.37 | |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |